(Q33736496)

29 July 2017

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States (English)

1 reference

Helicobacter pylori infectious disease

29 July 2017

1 reference

1 reference

1 reference

1 reference

M S Osato

1

1 reference

PubMed ID

10493611

29 July 2017

R Reddy

series ordinal

2

1 reference

PubMed ID

10493611

29 July 2017

D Y Graham

series ordinal

3

1 reference

29 July 2017

1 August 1999

1 reference

International Journal of Antimicrobial Agents

29 July 2017

1 reference

29 July 2017

12

1 reference

29 July 2017

4

1 reference

29 July 2017

341-347

1 reference

Factors influencing the eradication of Helicobacter pylori with triple therapy

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Resistance of Helicobacter pylori to antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Role of metronidazole resistance in therapy of Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Peptic ulcer disease in the 1990s: an Asian perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Comparison of agar based media for primary isolation of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Combination treatment with ranitidine is highly efficient against Helicobacter pylori despite negative impact of macrolide resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Role of the phosphoroclastic reaction of Clostridium pasteurianum in the reduction of metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Metronidazole uptake in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Proposed mechanism for metronidazole resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

The mode of action of metronidazole in Helicobacter pylori: futile cycling or reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900079-5

7 January 2021

10.1016/S0924-8579(99)00079-5

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10493611